| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/12/2013 | CA2336250C Anti-ccr2 antibodies and methods of use therefor |
| 02/07/2013 | WO2013019966A1 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | WO2013019938A1 Pyridazine derivatives as eaat2 activators |
| 02/07/2013 | WO2013019731A2 Phosphate prodrugs |
| 02/07/2013 | WO2013019548A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/07/2013 | WO2013019163A1 Paraffin in therapy and as a cosmetic preparation |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | WO2013018766A1 Stable pharmaceutical composition |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013018372A1 Amide derivative and drug containing same |
| 02/07/2013 | WO2013018371A1 Biaryl ester derivative and drug containing same |
| 02/07/2013 | WO2013017619A1 Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta |
| 02/07/2013 | WO2013017480A1 Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| 02/07/2013 | WO2013017479A1 Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| 02/07/2013 | US20130035754 Drug-delivery endovascular stent and method of forming the same |
| 02/07/2013 | US20130035635 Carrier-linked carbamate prodrug linkers |
| 02/07/2013 | US20130035383 Liquid/liquid extraction |
| 02/07/2013 | US20130035369 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 02/07/2013 | US20130035364 Benzylidene-indolinone compounds and their medical use |
| 02/07/2013 | US20130035363 Thalidomide Analogs |
| 02/07/2013 | US20130035362 Stable Anti-inflammatory Solutions for Injection |
| 02/07/2013 | US20130035360 Novel water soluble furoxan derivatives having antitumor activity |
| 02/07/2013 | US20130035359 Compositions containing aromatic aldehydes and their use in treatments |
| 02/07/2013 | US20130035358 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 02/07/2013 | US20130035357 Compositions and Methods for Preventing Joint Destruction in Osteoarthritis |
| 02/07/2013 | US20130035352 Gaba conjugates and methods of use thereof |
| 02/07/2013 | US20130035347 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 02/07/2013 | US20130035345 Solid dispersion formulations and methods of use thereof |
| 02/07/2013 | US20130035339 Apoptosis signal-regulating kinase inhibitors |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035334 Inhibitors of bruton's tyrosine kinase |
| 02/07/2013 | US20130035333 Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130035320 Pyrrolidine derivatives |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130035310 Piperidine and Piperazine Phenyl Sulfonamides as Modulators of Ion Channels |
| 02/07/2013 | US20130035305 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
| 02/07/2013 | US20130035286 Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues |
| 02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
| 02/07/2013 | US20130034599 Synthetic nanostructures including nucleic acids and/or other entities |
| 02/07/2013 | US20130034595 Local administration of gallium compositions to treat pain |
| 02/07/2013 | US20130034569 Il-18 receptor antigen binding proteins |
| 02/07/2013 | US20130034554 Antibodies to il-6 and use thereof |
| 02/07/2013 | US20130034541 Pharmaceutical compositions |
| 02/07/2013 | US20130034536 Bile Acid Recycling Inhibitors for Treatment of Pancreatitis |
| 02/07/2013 | US20130034510 Melanin modification compositions and methods of use |
| 02/07/2013 | US20130034504 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 02/07/2013 | US20130034495 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| 02/07/2013 | US20130034493 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/07/2013 | US20130034492 Class I Anti-CEA Antibodies and Uses Thereof |
| 02/07/2013 | CA2844152A1 Stable anti-inflammatory solutions for injection |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2842394A1 Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta |
| 02/07/2013 | CA2842362A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/06/2013 | EP2554542A1 Phenylalanine derivative salt crystal |
| 02/06/2013 | EP2554532A1 Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta |
| 02/06/2013 | EP2554169A1 Pharmaceutical preparation comprising phenylalanine derivative |
| 02/06/2013 | EP2554164A1 Pharmaceutical formulation based on ibuprofen and codeine having having improved stability |
| 02/06/2013 | EP2552932A1 Adenosine compounds and their use thereof |
| 02/06/2013 | EP2552920A1 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 02/06/2013 | EP2552916A1 Purine compounds used as cb2 agonists |
| 02/06/2013 | EP2552908A2 Heterocyclic compounds and their uses |
| 02/06/2013 | EP2552906A1 Cgrp receptor antagonist |
| 02/06/2013 | EP2552888A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion" |
| 02/06/2013 | EP2552886A1 Cytokine inhibitors |
| 02/06/2013 | EP2552472A2 Anti-inflammatory factors |
| 02/06/2013 | EP2552459A1 Method of treating inflammation |
| 02/06/2013 | EP2552397A2 Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate |
| 02/06/2013 | EP2552214A1 Pyrazolyl-pyrimidines as kinase inhibitors |
| 02/06/2013 | EP2552211A1 Indazolyl-pyrimidines as kinase inhibitors |
| 02/06/2013 | CN102918156A Single-strand nucleic acid molecule for controlling gene expression |
| 02/06/2013 | CN102918046A Inhibitors of jnk |
| 02/06/2013 | CN102918042A 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds |
| 02/06/2013 | CN102918040A Purinone derivative |
| 02/06/2013 | CN102918035A 2 -amino- pyrimidine derivatives useful as inhibitors of jnk |
| 02/06/2013 | CN102917718A Mesenchymal stem cell inducer, and method for induction of mesenchymal stem cell |
| 02/06/2013 | CN102917715A Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents |
| 02/06/2013 | CN102917703A Novel EP4 agonist |
| 02/06/2013 | CN102917699A Dendrimer compositions and methods of synthesis |
| 02/06/2013 | CN102911987A Cells of which genome is modified |
| 02/06/2013 | CN102911843A Preparation method of eclipta alba hair-blacking wine |
| 02/06/2013 | CN102911279A Polysaccharide-peptide and liposome thereof |
| 02/06/2013 | CN102911260A Antagonists against interaction of PF4 and RANTES |
| 02/06/2013 | CN102911179A Lcotinib hydrochloride crystal form, medicinal composition and application |
| 02/06/2013 | CN102911163A Quinazoline derivatives, composition containing derivatives and pharmaceutical application of derivatives |
| 02/06/2013 | CN102908612A Applications of TRAIL truncated mutant in activating NF-kappaB and in inflammatory responses |
| 02/06/2013 | CN102908600A Preparation method for ease pills |
| 02/06/2013 | CN102908597A Greenhouse disease curing capsule |
| 02/06/2013 | CN102908594A Anti-influenza and anti-common-cold Chinese herbal compound prescription and preparation method and application thereof |
| 02/06/2013 | CN102908588A Medicament for treating rigid rhachitis |
| 02/06/2013 | CN102908585A Traditional Chinese medicine for treating ischioneuralgia |
| 02/06/2013 | CN102908535A Medicinal liquor for treating pains in waist and lower extremities |
| 02/06/2013 | CN102908509A Drug for treating child acute benign myositis |
| 02/06/2013 | CN102908507A Medicament for treating bone disease |
| 02/06/2013 | CN102908498A Pharmaceutical composition for clearing away heat and toxic materials and method for preparing the same |